GMAB

Conviction 79HealthcareScan · Thu, Sep 24, 2026

Genmab A/S (GMAB) closed at $34.82 (+0.20%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 63, RS Rating 89, -1.5% from its 52-week high, +9.4% year to date. Sector: Healthcare · Biotechnology.

GMAB$34.82+0.20%

ResistanceSupportVol 14Congress buyCongress sell

Vol MA14 2.07M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

GENMAB A/SBiotechnologywww.genmab.com ↗

Price34.82

Change+0.20%

Gap-0.24%

Rel volume1.37×

Avg volume1.93M

Avg $ vol65.67M

SMA 2033.86

SMA 5031.89

SMA 20029.52

Price vs 50+9.20%

Price vs 200+17.97%

MA stackbullish

50/200 cross—

Supertrendup · 32.74

RSI (14)63

MACD hist0.01

MACD crossbull · 2d

Stoch %K / %D76 / 82

ADX (14)27

+DI / −DI35 / 19

RSI divergenceBearish

MACD divergenceBearish

ATR %2.27%

ADR %2.02%

52w high35.34

52w low23.85

From 52w high-1.47%

Above 52w low+46.00%

New 52w highNo

SqueezeOff

Bollinger width10.04%

%B0.78

Donchian pos75.65%

Donchian high35.66

Donchian low32.21

AVWAP (52w high)34.87

vs AVWAP high-0.14%

AVWAP (52w low)30.42

vs AVWAP low+14.45%

OBV trendUp

Chaikin MF (20)-0.00

Today vs 20d1.37×

Avg vol (14d)2.07M

Avg vol (20d)1.93M

Avg $ vol (20d)65.67M

Market cap21.38B

RS Rating89 / 99

RS 3m (vs SPY)+28.71%

RS 6m (vs SPY)+16.54%

RS line new highNo

Trend template6/8

Technical rank89.0

1 week+0.83%

1 month+1.34%

3 months+33.21%

6 months+33.36%

1 year+21.20%

YTD+9.43%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target94.19

Target upside170.51%

Analyst ratingBuy

Institutional16.65%

Ent. value21.38B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out623.53M

Employees3.09K

ListedTue, Oct 5, 2010

Free float589.61M

Float %95.9%

Short interest6.83M

Days to cover2.4d

Short volume65.3%

Squeeze score37 / 100

Next earningsThu, Nov 5, 2026 · pre-mkt (42d)

EPS forecast$0.37 · 5 est

Last EPS vs est$0.54 vs $0.37

Last surprise+46.0% beat

Setup gradeA

Conviction79 / 100

Pattern quality—

Tech rank89.0 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance34.56

Support29.50

Days since event—

Candle confirm—

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 15 – Aug 5
8 scans
→
Breaking out now
Aug 6
1 scan
→
Setting up
Aug 31 – Sep 18
8 scans

Congress activity

Disclosed STOCK Act trades in GMAB · 5 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Alan Armstrong senate · R · OK · traded 2026-03-30	Buy	$1K–$15K	2026-03-30	2026-07-21	PDF
Josh Gottheimer house · D · NJ · traded 2025-01-16	Buy	$1K–$15K	2025-01-16	2025-02-10	PDF
Josh Gottheimer house · D · NJ · traded 2024-12-16	Sell	$1K–$15K	2024-12-16	2025-01-14	PDF
Josh Gottheimer house · NJ · traded 2024-07-19	Buy	$1K–$15K	2024-07-19	2024-08-12	PDF
Josh Gottheimer house · NJ · traded 2024-06-18	Sell	$1K–$15K	2024-06-18	2024-07-08	PDF

Insider activity

SEC Form 4 transactions in GMAB

No recent insider (Form 4) filings in GMAB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GMAB · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.